Latest news

Debiopharm Forges AI-Powered Alliance with NetTargets to Pioneer Dual-Payload ADCs Against Drug-Resistant Cancers

Debiopharm Licenses SunRock Biopharma’s anti-HER3/HER2 Antibody to Explore the Full Potential of Bispecific ADC Debio 2512